References
- Emami A, Javanmardi F, Pirbonyeh N, Akbari A. Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis. Arch Acad Emerg Med. 2020;8(1):e35.
- Grasselli G, Zangrillo A, Zanella A, et al.; COVID-19 Lombardy ICU Network. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323(16):1574–1581. doi:10.1001/jama.2020.5394
- Goyal P, Choi JJ, Pinheiro LC, et al. Clinical characteristics of Covid-19 in New York City. N Engl J Med. 2020;382(24):2372–2374. doi:10.1056/NEJMc2010419
- Momtazmanesh S, Moghaddam SS, Ghamari S-H; GBD 2019 Chronic Respiratory Diseases Collaborators. Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019. EClinicalMedicine. 2023;59:101936. doi:10.1016/j.eclinm.2023.101936
- Viniol C, Vogelmeier CF. Exacerbations of COPD. Eur Respir Rev. 2018;27(147):170103. doi:10.1183/16000617.0103-2017
- Global Initiative for Asthma (GINA). Global strategy for the diagnosis and prevention. Global Initiative for Asthma (updated 2020); 2020. Available from: http://ginasthma.org/wpcontent/uploads/2020/04/GINA-2020-full-report_-final. Accessed August 24, 2023.
- Centers for Disease Control and Prevention. National Center for Health Statistics – homepage; 2020. Available from: https://www.cdc.gov/nchs/. Accessed August 24, 2023.
- Halpin DMG, Faner R, Sibila O, Badia JR, Agusti A. Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection? Lancet Respir Med. 2020;8(5):436–438. doi:10.1016/S2213-2600(20)30167-3
- Alqahtani JS, Oyelade T, Aldhahir AM, et al. Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: a Rapid Systematic Review and Meta-Analysis. PLoS One. 2020;15(5):e0233147. doi:10.1371/journal.pone.0233147
- Zhao Q, Meng M, Kumar R, et al. The impact of COPD and smoking history on the severity of COVID-19: a systemic review and meta-analysis. J Med Virol. 2020;92(10):1915–1921. doi:10.1002/jmv.25889
- Olsen SJ, Azziz-Baumgartner E, Budd AP, et al. Decreased Influenza Activity During the COVID-19 Pandemic - United States, Australia, Chile, and South Africa, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(37):1305–1309. doi:10.15585/mmwr.mm6937a6
- McAuley H, Hadley K, Elneima O, et al. COPD in the time of COVID-19: an analysis of acute exacerbations and reported behavioural changes in patients with COPD. ERJ Open Res. 2021;7(1):00718–2020. doi:10.1183/23120541.00718-2020
- Alqahtani JS, Oyelade T, Aldhahir AM, et al. Reduction in hospitalised COPD exacerbations during COVID-19: a systematic review and meta-analysis. PLoS One. 2021;16(8):e0255659. doi:10.1371/journal.pone.0255659
- Vishak AK, Unnikrishnan B, Sindhu K, et al. Have guidelines been oblivious to the obvious? Unmasking the positives from the COVID-19 pandemic. NPJ Prim Care Respir Med. 2021;31(1):11. doi:10.1038/s41533-021-00224-0
- Alsallakh MA, Sivakumaran S, Kennedy S, et al. Impact of COVID-19 lockdown on the incidence and mortality of acute exacerbations of chronic obstructive pulmonary disease: national interrupted time series analyses for Scotland and Wales. BMC Med. 2021;19(1):124. doi:10.1186/s12916-021-02000-w